Kashif Rasheed

Mr. Kashif Rasheed

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
KFKaiji Fan
Kaiji Fan
JGJan Gravemeyer
Jan Gravemeyer
CRCathrin Ritter
Cathrin Ritter
KRKashif Rasheed
Kashif Rasheed
Thilo GambichlerThilo Gambichler
Thilo Gambichler
Jürgen C. BeckerJürgen C. Becker
Jürgen C. Becker

10 April 2015 in Viruses
Verified
Journal Article
Open access
PDF file
UMUgo Moens
Ugo Moens
KRKashif Rasheed
Kashif Rasheed
IAIbrahim Abdulsalam
Ibrahim Abdulsalam
BSBaldur Sveinbjønrsson
Baldur Sveinbjønrsson
Polyomaviruses are non-enveloped, dsDNA viruses that are common in mammals, including humans. All polyomaviruses encode the large T-antigen and small t-antigen proteins that share conserved functional domains, comprising binding motifs for the tumor suppressors pRb and p53, and for protein phosphatase 2A, respectively. At present, 13 different human polyomaviruses are known, and for some of them their large T-antigen and small t-antigen have been shown to possess oncogenic properties in cell culture and animal models, while similar functions are assumed for the large T- and small t-antigen of other human polyomaviruses. However, so far the Merkel cell polyomavirus seems to be the only human polyomavirus associated with cancer. The large T- and small t-antigen exert their tumorigenic effects through classical hallmarks of cancer: inhibiting tumor suppressors, activating tumor promoters, preventing apoptosis, inducing angiogenesis and stimulating metastasis. This review elaborates on the putative roles of human polyomaviruses in some of the emerging hallmarks of cancer. The reciprocal interactions between human polyomaviruses and the immune system response are discussed, a plausible role of polyomavirus-encoded and polyomavirus-induced microRNA in cancer is described, and the effect of polyomaviruses on energy homeostasis and exosomes is explored. Therapeutic strategies against these emerging hallmarks of cancer are also suggested.

31 July 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
KRKashif Rasheed
Kashif Rasheed
IAIbrahim Abdulsalam
Ibrahim Abdulsalam
SFSilje Fismen
Silje Fismen
ØGØystein Grimstad
Øystein Grimstad
BSBaldur Sveinbjørnsson
Baldur Sveinbjørnsson
UMUgo Moens
Ugo Moens
CCL17/TARC and CCR4 expression in Merkel Cell Carcinoma CCL17/TARC and CCR4 expression in Merkel Cell Carcinoma

19 April 2020 in Virology Journal
Verified
Journal Article
Open access
PDF file
IAIbrahim Abdulsalam
Ibrahim Abdulsalam
KRKashif Rasheed
Kashif Rasheed
BSBaldur Sveinbjønrsson
Baldur Sveinbjønrsson
BEBernhard Ehlers
Bernhard Ehlers
UMUgo Moens
Ugo Moens
Background: Merkel cell polyomavirus (MCPyV) is a human polyomavirus that establishes a life-long harmless infection in most individuals, with dermal fibroblasts believed to be the natural host cell. However, this virus is the major cause of Merkel cell carcinoma (MCC), an aggressive skin cancer. Several MCPyV variants with polymorphism in their promoter region have been isolated, but it is not known whether these differences affect the biological properties of the virus. Methods: Using transient transfection studies in human dermal fibroblasts and the MCC cell line MCC13, we compared the transcription activity of the early and late promoters of the most commonly described non-coding control region MCPyV variant and six other isolates containing specific mutation patterns. Results: Both the early and late promoters were significantly stronger in human dermal fibroblasts compared with MCC13 cells, and a different promoter strength between the MCPyV variants was observed. The expression of full-length large T-antigen, a viral protein that regulates early and late promoter activity, inhibited early and late promoter activities in both cell lines. Nonetheless, a truncated large T-antigen, which is expressed in virus-positive MCCs, stimulated the activity of its cognate promoter. Conclusion: The promoter activities of all MCPyV variants tested was stronger in human dermal fibroblasts, a cell line that supports viral replication, than in MCC13 cells, which are not permissive for MCPyV. Truncated large T-antigen, but not full-length large T-antigen stimulated viral promoter activity. Whether, the difference in promoter strength and regulation by large T-antigen may affect the replication and tumorigenic properties of the virus remains to be determined.

Verified
Journal Article
Open access
PDF file
KRKashif Rasheed
Kashif Rasheed
UMUgo Moens
Ugo Moens
BPBenedetta Policastro
Benedetta Policastro
JJJohn Inge Johnsen
John Inge Johnsen
VKVirve Koljonen
Virve Koljonen
BSBaldur Sveinbjønrsson
Baldur Sveinbjønrsson
Merkel cell polyomavirus (MCPyV) is a causal factor in Merkel cell carcinoma (MCC). The oncogenic potential is mediated through its viral oncoproteins large T-antigen (LT) and small T-antigen (sT). Cytokines produced by tumor cells play an important role in cancer pathogenesis, and viruses affect their expression. Therefore, we compared human cytokine and receptor transcript levels in virus positive (V+) and virus negative (V−) MCC cell lines. Increased expression of IL-33, a potent modulator of tumor microenvironment, was observed in V+ MCC cell lines when compared to V− MCC-13 cells. Transient transfection studies with luciferase reporter plasmids demonstrated that LT and sT stimulated IL-33, ST2/IL1RL1 and IL1RAcP promoter activity. The induction of IL-33 expression was confirmed by transfecting MCC-13 cells with MCPyV LT. Furthermore, recombinant human cytokine domain IL-33 induced activation of MAP kinase and NF-κB pathways, which could be blocked by a ST2 receptor antibody. Immunohistochemical analysis demonstrated a significantly stronger IL-33, ST2, and IL1RAcP expression in MCC tissues compared to normal skin. Of interest, significantly higher IL-33 and IL1RAcP protein levels were observed in MCC patient plasma compared to plasma from healthy controls. Previous studies have demonstrated the implication of the IL-33/STL2 pathway in cancer. Because our results revealed a T-antigens-dependent induction of the IL-33/ST2 axis, IL-33/ST2 may play a role in the tumorigenesis of MCPyV-positive MCC. Therefore, neutralizing the IL-33/ST2 axis may present a novel therapeutic approach for MCC patients.

31 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SKStine Kristensen
Stine Kristensen
CÅCharlotte Årseth
Charlotte Årseth
MYMaria Yurchenko
Maria Yurchenko
LRLiv Ryan
Liv Ryan
IFIda Fjellvær
Ida Fjellvær
TFTrude Helen Flo
Trude Helen Flo
The cell-intrinsic complement system has emerged as an important orchestrator of a variety of cell-physiological processes, with complement components interacting with intracellular effector systems to regulate cellular responses to pathogens or noxious stimuli. For instance, intracellular C5 signaling through a mitochondrial C5a receptor (C5aR1) controls IL-1β production in human monocytes and macrophages. Here, we investigated whether cell-intrinsic C3 similarly regulates inflammatory responses in macrophages. In LPS-stimulated C3 knockout THP-1-derived macrophages, interferon (IFN)-β production was increased, accompanied by elevated expression of interferon-stimulated genes and enhanced secretion of IFN-induced cytokines and chemokines. C3-deficient cells showed increased phosphorylation of IRF3 at Ser 396 and a stabilization of the interaction between IRF3 and TBK1, along with enhanced IRF3 dimerization and nuclear translocation. TBK1 phosphorylation was unaffected, indicating that C3 limits IRF3-TBK1 complex formation rather than upstream TBK1 activation. Small-molecule inhibitors of complement factors B and D restored full-length C3 abundance in LPS-stimulated primary human macrophages, consistent with inhibition of the C3 convertase. It also reduced LPS-induced IFN-β production in primary human macrophages and THP-1 cells, suggesting that full-length, uncleaved C3 suppresses IFN-β production. Collectively, these findings identify cell-intrinsic C3 as a suppressor of IFN-β production in human macrophages, highlighting the importance of the cell-intrinsic complement system in fine-tuning inflammatory responses to pathogens. One sentence summary: Cell-intrinsic, full-length C3 suppresses IFN-β production in macrophages by limiting IRF3-TBK1 complex formation, highlighting the role of cell-intrinsic complement in regulating inflammatory responses to pathogens.